Privia Health Group Inc
NASDAQ:PRVA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/OCF
Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.
Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.
Valuation Scenarios
If EV/OCF returns to its 3-Year Average (23.7), the stock would be worth $37.98 (58% upside from current price).
| Scenario | EV/OCF Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 15 | $24.02 |
0%
|
| 3-Year Average | 23.7 | $37.98 |
+58%
|
| 5-Year Average | 35 | $56.04 |
+133%
|
| Industry Average | 18.7 | $29.89 |
+24%
|
| Country Average | 16.7 | $26.7 |
+11%
|
Forward EV/OCF
Today’s price vs future operating cash flow
Peer Comparison
| Market Cap | EV/OCF | P/E | ||||
|---|---|---|---|---|---|---|
| US |
|
Privia Health Group Inc
NASDAQ:PRVA
|
3B USD | 15 | 127.2 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
98.2B USD | 13.8 | 54.9 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
68.3B EUR | 10.5 | 13.2 | |
| US |
|
Cigna Corp
NYSE:CI
|
73.4B USD | 0 | 12.3 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
24.7B EUR | 13 | 19.5 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
22.8B EUR | 11 | 23.4 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
22.2B USD | 16.2 | 25.3 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
21.5B USD | 13.9 | 21.8 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11B EUR | 6.6 | 11.3 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
11.8B USD | -67.3 | -28.6 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.1B USD | 10.3 | 13.7 |
Market Distribution
| Min | 0 |
| 30th Percentile | 11.7 |
| Median | 16.7 |
| 70th Percentile | 23.6 |
| Max | 3 178 983.5 |
Other Multiples
Privia Health Group Inc
Glance View
Privia Health Group Inc. is a compelling tale of innovation in the healthcare space, driven by its unique approach to physician enablement. Founded on the principle of enhancing the operational efficiency of medical practices, Privia Health partners with physicians to help them deliver high-quality care while navigating the complexities of modern healthcare systems. By providing a robust technology platform alongside a comprehensive suite of clinical, financial, and operational services, Privia empowers doctors to maintain their independence while benefiting from the support and scale typically enjoyed by larger healthcare organizations. This model not only enhances patient care but also aligns with value-based care initiatives by focusing on outcomes rather than solely on the volume of services provided. The company's revenue engine is fueled by several streams. Primarily, Privia generates earnings through management service agreements with the practices it partners with. These agreements involve sharing savings that result from improved care coordination and operational efficiencies, part of which are attributed to the physicians and part retained by Privia. Additionally, the organization benefits from its participation in value-based care contracts, where performance metrics tied to quality and cost can lead to shared savings arrangements with payers. This alignment of interests between Privia, the physicians, and the payers forms a sustainable business model that prioritizes both profitability and improved patient outcomes, setting a new benchmark in the healthcare landscape.